Payment overview · 2025
General Payments
$260.77
13 reported records · 6 companies
Healthcare provider profile · identity verified
Ebonee L Davis, MD
Allopathic & Osteopathic Physicians|Internal Medicine · SOUTH BEND, IN · NPI 1295725646
Verified facts
What the public records show
CMS Open Payments records show Ebonee L Davis, MD received $260.77 in general payments during 2025 across 13 reported records.
Novo Nordisk Inc accounted for 46.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 90 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $120.33 | 46.1% | 5 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $59.69 | 22.9% | 4 | 2025 |
| Insulet Corporation | Unresolved — no canonical attribution shown | $29.20 | 11.2% | 1 | 2025 |
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $20.20 | 7.8% | 1 | 2025 |
| Supernus Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $16.15 | 6.2% | 1 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $15.20 | 5.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $260.77 | 13 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $59.69 | 4 | 2025 |
Source payment records
|
|||||
| Omnipod Normalized: omnipod |
Device | Insulet Corporation | $29.20 | 1 | 2025 |
Source payment records
|
|||||
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $20.20 | 1 | 2025 |
Source payment records
|
|||||
| Qelbree Normalized: qelbree |
Drug | Supernus Pharmaceuticals, Inc. | $16.15 | 1 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $15.20 | 1 | 2025 |
Source payment records
|
|||||
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $13.53 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
90 | 14 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 887 | 234 |
| Amlodipine Besylate | Amlodipine Besylate | 686 | 180 |
| Levothyroxine Sodium | Levothyroxine Sodium | 614 | 124 |
| Montelukast Sodium | Montelukast Sodium | 553 | 142 |
| Losartan Potassium | Losartan Potassium | 407 | 105 |
| Lisinopril | Lisinopril | 364 | 97 |
| Fluticasone Propionate | Fluticasone Propionate | 333 | 126 |
| Pantoprazole Sodium | Pantoprazole Sodium | 326 | 88 |
| Omeprazole | Omeprazole | 244 | 63 |
| Tramadol Hcl | Tramadol Hcl | 241 | 62 |
| Glimepiride | Glimepiride | 234 | 60 |
| Metformin Hcl | Metformin Hcl | 232 | 58 |
| Gabapentin | Gabapentin | 225 | 79 |
| Escitalopram Oxalate | Escitalopram Oxalate | 223 | 62 |
| Potassium Chloride | Potassium Chloride | 207 | 47 |
| Simvastatin | Simvastatin | 198 | 57 |
| Mounjaro | Tirzepatide | 196 | 25 |
| Hydrochlorothiazide | Hydrochlorothiazide | 189 | 55 |
| Alendronate Sodium | Alendronate Sodium | 185 | 45 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 181 | 60 |
| Diclofenac Sodium | Diclofenac Sodium | 178 | 59 |
| Furosemide | Furosemide | 178 | 46 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 172 | 48 |
| Pravastatin Sodium | Pravastatin Sodium | 161 | 45 |
| Eliquis | Apixaban | 160 | 28 |
| Meloxicam | Meloxicam | 155 | 44 |
| Metoprolol Succinate | Metoprolol Succinate | 148 | 41 |
| Buspirone Hcl | Buspirone Hcl | 130 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 127 | 34 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 122 | 32 |
| Mirtazapine | Mirtazapine | 119 | 27 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 116 | 27 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 114 | 21 |
| Ezetimibe | Ezetimibe | 110 | 34 |
| Trazodone Hcl | Trazodone Hcl | 108 | 33 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 107 | 28 |
| Januvia | Sitagliptin Phosphate | 104 | 26 |
| Sertraline Hcl | Sertraline Hcl | 99 | 24 |
| Atenolol | Atenolol | 97 | 25 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 97 | 22 |
| Glipizide Er | Glipizide | 90 | 23 |
| Ozempic | Semaglutide | 90 | 14 |
| Bupropion Xl | Bupropion Hcl | 89 | 31 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 87 | 27 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 85 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 82 | 23 |
| Carvedilol | Carvedilol | 78 | 24 |
| Pioglitazone Hcl | Pioglitazone Hcl | 78 | 25 |
| Metformin Hcl Er | Metformin Hcl | 76 | 18 |
| Famotidine | Famotidine | 75 | 22 |
| Labetalol Hcl | Labetalol Hcl | 75 | 23 |
| Clopidogrel | Clopidogrel Bisulfate | 74 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 74 | 35 |
| Topiramate | Topiramate | 74 | 16 |
| Trulicity | Dulaglutide | 73 | 12 |
| Metoprolol Tartrate | Metoprolol Tartrate | 68 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 67 | 21 |
| Tamsulosin Hcl | Tamsulosin Hcl | 67 | 23 |
| Breo Ellipta | Fluticasone/Vilanterol | 66 | 16 |
| Ibuprofen | Ibuprofen | 65 | 16 |
| Alprazolam | Alprazolam | 63 | 22 |
| Prednisone | Prednisone | 63 | 35 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 58 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 57 | 19 |
| Nystatin | Nystatin | 54 | 32 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 52 | 16 |
| Doxycycline Hyclate | Doxycycline Hyclate | 52 | 44 |
| Spironolactone | Spironolactone | 52 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 52 | 19 |
| Synthroid | Levothyroxine Sodium | 51 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | 23 |
| Allopurinol | Allopurinol | 47 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 47 | 41 |
| Clonazepam | Clonazepam | 47 | suppressed |
| Xarelto | Rivaroxaban | 47 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | suppressed |
| Cephalexin | Cephalexin | 45 | 36 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 44 | 13 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 42 | 28 |
| Fenofibrate | Fenofibrate Nanocrystallized | 40 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 38 | 12 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 38 | suppressed |
| Levetiracetam | Levetiracetam | 38 | suppressed |
| Methylprednisolone | Methylprednisolone | 38 | 31 |
| Doxazosin Mesylate | Doxazosin Mesylate | 37 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Acarbose | Acarbose | 35 | 12 |
| Pregabalin | Pregabalin | 35 | 12 |
| Valsartan | Valsartan | 35 | suppressed |
| Eszopiclone | Eszopiclone | 34 | 14 |
| Donepezil Hcl | Donepezil Hcl | 33 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 33 | suppressed |
| Nifedipine Er | Nifedipine | 33 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 33 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 32 | 14 |
| Glipizide | Glipizide | 32 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 32 | suppressed |
| Estradiol | Estradiol | 31 | 11 |
| Propranolol Hcl Er | Propranolol Hcl | 29 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 28 | suppressed |
| Jardiance | Empagliflozin | 28 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 28 | suppressed |
| Ondansetron Odt | Ondansetron | 27 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 27 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 26 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 26 | 15 |
| Lovastatin | Lovastatin | 26 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 25 | 12 |
| Lansoprazole | Lansoprazole | 25 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 24 |
| Ropinirole Hcl | Ropinirole Hcl | 24 | suppressed |
| Temazepam | Temazepam | 24 | suppressed |
| Lorazepam | Lorazepam | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | 12 |
| Symbicort | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Celecoxib | Celecoxib | 22 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 22 | suppressed |
| Fluconazole | Fluconazole | 21 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 21 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 21 | suppressed |
| Chlorthalidone | Chlorthalidone | 20 | suppressed |
| Finasteride | Finasteride | 20 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 19 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Torsemide | Torsemide | 17 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 16 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | 14 |
| Diazepam | Diazepam | 15 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 15 | suppressed |
| Ramipril | Ramipril | 15 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Lubiprostone | Lubiprostone | 13 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 12 | suppressed |
| Entresto | Sacubitril/Valsartan | 12 | suppressed |
| Hydrocodone-Ibuprofen | Hydrocodone/Ibuprofen | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Victoza 3-Pak | Liraglutide | 12 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 11 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
| Veo Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $260.77 · 13 records | Novo Nordisk Inc | AZUR CX DETACHABLE, EVENITY, INSPIRE, Omnipod, PROLIA, Qelbree | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error